Cancer drug shows promise against graft versus host disease
Sunday, July 13, 2008 - 10:49
in Health & Medicine
A new University of Michigan study in mice suggests that a drug recently approved to fight cancer tumours is also able to reduce the effects of graft-versus-host disease, a common and sometimes fatal complication for people who have had bone marrow transplants...
Read the whole article on Science Centric
More from Science Centric
Related
- Cancer drug shows promise against graft vs. host diseaseThu, 10 Jul 2008, 16:35:50 EDT
- Strategy for mismatched stem cell transplants triggers protection against graft-vs.-host diseaseWed, 7 Oct 2009, 15:18:36 EDT
- Gene mismatch influences success of bone marrow transplantsSun, 22 Nov 2009, 14:50:48 EST
- Bone marrow transplant patients may benefit from new immune researchWed, 11 Feb 2009, 17:37:30 EST
- UNC study hints at new approaches to prevent transplant rejectionWed, 11 Feb 2009, 11:17:14 EST